WOS

Permanent URI for this collectionhttps://hdl.handle.net/11443/932

Browse

Has files: NoSubject: search.filters.subject.Colon

Search Results

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    The effect of Hericium erinaceum on the prevention of chemically induced experimental colitis in rats
    (KOREAN ASSOC INTERNAL MEDICINE, 2021-01-01) Durmus, Ali; Durmus, Ilgim; Bender, Omer; Karatepe, Oguzhan
    Background/Aims: The aim of this study is to investigate the effects of the Hericium erinaceum on an experimental colitis model. Methods: Twenty-four Wistar albino were included in this study. Rats were divided into three groups. Group 1 (n = 8) was sham group. Group 2 is the group of chemically induced by intrarectal administration of trinitrobenzene sulfonic acid (TNBS) resulting in colitis. Group 3 (n = 8) is the group that was treated 7 days before and 7 days after with H. erinaceum resulting in colitis. The activity of colitis was evaluated macroscopically and microscopically in rats. In other words, nitric oxide (NO) levels, malondialdehyde (MDA), interleukin 6 (IL-6), nuclear factor-kappa B (NF-kappa B) and, tumor necrosis factor-alpha (TNF-alpha) in addition to the myeloperoxidasem (MPO) activities was determined. Results: The rate of TNBS-induced colitis caused to increase the level of MDA activities meaningfully in the colitis group than the control group. The results indicated that MDA (p = 0.001), NO (p = 0.001), IL-6 (p = 0.001), MPO (p = 0.878), TNF-alpha (p = 0.004 and NF-kappa B levels of treatment group decreased in the blood and colon tissues because of the H. erinaceum treatment when compared to the colitis group. H. erinaceum treatment was related to the declining of MDA, NF-kappa B, NO, IL-6, and TNF-alpha levels. Conclusions: H. erinaceum had a positive effect on the colitis by reducing oxidative damage in blood and tissue.
  • No Thumbnail Available
    Item
    Colonic Malignant Melanoma: F-18-FDG PET/CT Findings
    (GALENOS YAYINCILIK, 2018-01-01) Kaya, Eser; Aksoy, Tamer; Guner, Ahmet Levent; Temiz, Hakan; Vardareli, Erkan
    Primary malignant melanoma occurs most often in the skin and much less frequently in the choroid layer of the eyes, in the leptomeninges, oral cavity, nasal mucosa, pharynx, esophagus, bronchus, under the nail and vaginal or anorectal mucosa. Primary melanoma of the gastrointestinal tract has been confirmed for lesions occurring in the esophagus, stomach, small bowel, and anorectum through several published reports, as these are the areas where melanocytes normally exist. The occurrence of primary malignant melanoma in the colon is relatively rare, because melanocytes are embryologically absent in the large bowel. Herein we report a patient whose colonic malignant melanoma was diagnosed and disseminated metastatic lesions were revealed with F-18-FDG PET/CT scan. There were multiple nodular lesions showing increased F-18-FDG uptake in both lungs. There was a soft tissue lesion with slightly increased F-18-FDG uptake, which extended to the intraluminal region of the thoracic esophagus. Increased metabolic activity was detected in the asymmetric stomach wall thickening site and in a soft tissue lesion located on the gall bladder wall that was filling the lumen. Multiple hypodense/hyper-metabolic lesions were identified in the liver. Multiple hyper-metabolic polypoid soft tissue lesions were visualized in almost the entire colonic segments. Multiple hyper-metabolic peritoneal implants were noted in all abdominal quadrants. Increased F-18-FDG uptake was detected at the right surrenal gland soft tissue lesion. There was a hyper-metabolic soft tissue lesion on the posterior wall of the rectum. Hyper-metabolic lytic lesions were seen at the thoracal and lumbar vertebrae, left scapula, left iliac bone, sacrum and left femur. There was no evidence of F-18-FDG avid skin lesions in both attenuation corrected and non-corrected images.